Table 1 Baseline characteristics of the total population (n = 201).
Patients | |
|---|---|
Age (years) | 58 (51, 67) |
Male | 185 (82.6%) |
Previous disorder: | |
Myocardial infarction | 16 (7.1%) |
Angina pectoris | 7 (3.1%) |
Hypertension (treated) | 58 (25.9%) |
Hyperlipidaemia (treated) | 20 (8.9%) |
Status at baseline | |
Current smoker | 109 (48.7%) |
TnT maximum (ug/L) | 4.70 (2.45, 8.92) |
BMI (kg/m2) | 26 (24.4, 28.7) |
Waist circumference (cm) | 100 (94, 107) |
Stent in culprit lesion | 215 (96.0%) |
Gp IIb/IIIa antagonist treated | 79 (35.3%) |
Single -coronary vessel disease | 139 (62.1%) |
Double-coronary vessel disease | 64 (28.6%) |
Triple-coronary vessel disease | 21 (9.4%) |
Time from symptoms to balloon (min) | 219 (140, 378) |
Medication at three months (n = 201) | |
Aspirin | 200 (99.5%) |
Clopidogrel | 189 (94%) |
β-blockers | 188 (93.5%) |
Lipid lowering agents | 194 (96.5%) |
Angiotensin converting enzyme-inhibitors | 69 (34.3%) |
Angiotensin II-receptor blockers | 25 (12.4%) |
Glucose lowering medication | 0 |
LVEFa (%) | 64 (56, 70) |
Infarct sizea, % of left ventricular mass | 14.0 (0.0, 29.0) |